Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(21):1652; doi:10.1093/jnci/94.21.1652-a
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Partridge, A. H.
Right arrow Articles by Winer, E. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Partridge, A. H.
Right arrow Articles by Winer, E. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 21, 1652, November 6, 2002
© 2002 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Adherence to Therapy With Oral Antineoplastic Agents

Ann H. Partridge, Jerry Avorn, Philip S. Wang, Eric P. Winer

Affiliations of authors: A. H. Partridge, E. P. Winer, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA; J. Avorn, P. S. Wang, Brigham and Women’s Hospital, Boston.

Correspondence to: Eric P. Winer, M.D., Breast Oncology Center, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115 (e-mail: ewiner@partners.org).

The first 10% of the full text of this article appears below.

de Lemos highlights the involvement of pharmacists in patient education and points out their contribution in fostering . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?